Identification of Tumor Antigens and Immune Subtypes of High-grade Serous Ovarian Cancer for mRNA Vaccine Development

High-grade serous ovarian cancer (HGSC) is the most common pathology of ovarian cancer and has aggressive characteristics and poor prognosis. mRNA vaccines are a novel tool for cancer immune treatment and may play an important role in HGSC therapy. Our study aimed to explore tumour antigens for vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yanxuan, Li, Zhifeng, Lin, Hong, Wang, Hongbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539400/
https://www.ncbi.nlm.nih.gov/pubmed/37779866
http://dx.doi.org/10.7150/jca.87184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539400/
https://www.ncbi.nlm.nih.gov/pubmed/37779866
http://dx.doi.org/10.7150/jca.87184

Ejemplares similares